Studies of the Blood Ammonia in Liver Disease (1963)

Article1 January 1963Studies of the Blood Ammonia in Liver DiseaseIts Diagnostic, Prognostic, and Therapeutic SignificanceJULES STAHL, M.D., F.A.C.P. (HON.)JULES STAHL, M.D., F.A.C.P. (HON.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-58-1-1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptStudies on blood ammonia have a long experimental and biochemical record going back to the work of the Pavlov school on meat intoxication in dogs with Eck fistulas (1, 2). Later studies, using more satisfactory methods, were applied to the investigation of liver disease for the first time by Burchi in 1927 (3), by Van Caulaert and Deviller in their extensive studies in Strasbourg in 1932 (4), and by Esben Kirk in 1935 (5).Van Caulaert and Esben Kirk had noticed in cirrhotic subjects temporary elevation of the venous blood ammonia after an oral test dose of ammonium salts. They...References1. HAHNMASSENNENCKIPAVLOV MOMJ: Die Eck-sche Fistel zwischen der unteren Hohlvene und der Pfortader und ihre Folgen für den Organismus. Arch. Exp. Path. Pharmakol. 32: 161, 1893. CrossrefGoogle Scholar2. NENCKIPAVLOVZALESKI MJPJ: Ueber den Ammoniakgehalt des Blutes und der Organe. Die Harnstoffbildung bei den Säugetieren. Arch. Exp. Path. Pharmakol. 37: 26, 1896. CrossrefGoogle Scholar3. BURCHI R: Saggio della funzionalità epatica con la studio della ammoniaca spontana e provocata. Folia Clin. Chim. Micr. 1: 3, 1926. Google Scholar4. VAN CAULAERTDEVILLER CC: Ammoniémie expérimentale après ingention de chlorure d'ammonium chez l'homme à l'état normal et pathologique. C. R. Soc. Biol. (Par.) 3: 50, 1932. Google Scholar5. KIRK E: Amino-acid and Ammonia Metabolism in Liver Diseases, Lewis and Munksgard, Copenhagen, 1936, 147 pp. Google Scholar6. VAN CAULAERTDEVILLERHALFF CCM: Troubles provoqués par l'ingestion de sels ammoniacaux chez l'homme atteint de cirrhose de Laënnec. C. R. Soc. Biol. (Par.) 3: 739, 1932. Google Scholar7. VAN CAULAERTDEVILLERHALFF CCM: Contribution à l'étude des cirrhoses de Laënnec. Toxicité de l'ammoniaque. Presse Med. 41: 217, 1933. Google Scholar8. PHILLIPSSCHWARTZGABUZDADAVIDSON GBRGJCS: The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. New Engl. J. Med. 247: 239, 1952. CrossrefMedlineGoogle Scholar9. MCDERMOTTADAMS WVRD: Episodic stupor associated with an Eck-fistula in human with particular reference to the metabolism of ammonia. J. Clin. Invest. 33: 1, 1954. CrossrefMedlineGoogle Scholar10. MCDERMOTT WV: Metabolism and toxicity of ammonia. New Engl. J. Med. 257: 1076, 1957. CrossrefMedlineGoogle Scholar11. CHALMERS TC: Pathogenesis and treatment of hepatic failure. New Engl. J. Med. 263: 23, 77, 1960. CrossrefMedlineGoogle Scholar12. BOCKELIMLERFRICK RMA: Etudes des perturbations du métabolisme amoniacal au cours des affections hépatiques. 1. Méthode de dosage de l'ammoniaque du sang. Roentgen. Lab. Prax. 13: 100, 1960. Google Scholar13. CONWAY EJ: Apparatus for the micro-determination of certain volatile substances. IV. The blood ammonia with observations on normal human blood. Biochem. J. 29: 2755, 1935. CrossrefMedlineGoogle Scholar14. STAHLROGERBOCKEL JSR: Signification de l'ammoniémie provoquée au cours de diverses affections hépatiques. Acta Gastroent. Belg. 10: 846, 1955. Google Scholar15. STAHLROGERWITZ JSJ: Essai d'interprétation du mécanisme de l'épreuve d'hyperammoniémie provoquée chez les cirrhotiques. C. R. Soc. Biol. (Par.) 146: 1787, 1952. MedlineGoogle Scholar16. STAHLBOCKELIMLERKURTZROHMER JRMDF: Etude conjointe de l'ammoniémie artérielle et veineuse dans la cirrhose. I. La signification de l'ammoniémie artérielle et veineuse au cours de l'épreuve d'ammoniémie provoquée par ingestion de sels ammoniacauz. Déductions physiopathologiques et cliniques. Rev. Franc. Etud. Clin. Biol. 4: 447, 1959. MedlineGoogle Scholar17. STAHL J: Arterielle und venöse Blutammoniakstudien bei Leberkrankheiten. Deutsch. Med. J. 10: 325, 1959. MedlineGoogle Scholar18. STAHLBOCKELIMLERKURTZ JRMD: L'ammoniémie dans la cirrhose et ses complications. Rev. Méd. Chir. Mal Foie 35: 169, 1960. MedlineGoogle Scholar19. STAHLBOCKELIMLERKURTZ JRMD: Ammoniaque et coma hépatique. Rev. Méd. Suisse Rom. 81: 729, 1961. MedlineGoogle Scholar20. BESSMANBRADLEY SPJE: Uptake of ammonia by muscle. Its implication in ammoniogenic coma. New Engl. J. Med. 253: 1143, 1955. CrossrefMedlineGoogle Scholar21. BORNSTEINKEITEL AK: Ueber den Ammoniakstoffwechsel der normalen und der mit Bausäure vergifteten Extremität. Biochem. Z. 179: 117, 1926. Google Scholar22. BESSMANBESSMAN SPAN: The cerebral and peripheral uptake of ammonia in liver disease with a hypothesis for the mechanism of hepatic coma. J. Clin. Invest. 34: 622, 1955. CrossrefMedlineGoogle Scholar23. FRITTSHARDEWIGROCHESTERDURAND HWADJ: Detection of pulmonary arteriovenous shunts using intravenous injections of Kr 85 and T-1824 dye. J. Clin. Invest. 38: 1006, 1959. Google Scholar24. CALABRESIABELMANN PWH: Porto-caval and porto-pulmonary anastomoses in Laennec's cirrhosis and in heart failure. J. Clin. Invest. 36: 1257, 1957. CrossrefMedlineGoogle Scholar25. WHITEPHEARSUMMERSKILLSHERLOCK LPEAWHS: Ammonium tolerance in liver disease: observations based on catheterization of the hepatic vein. J. Clin. Invest. 34: 158, 1955. CrossrefMedlineGoogle Scholar26. CONN HO: Ammonia tolerance in liver disease. J. Lab. Clin. Med. 55: 855, 1960. MedlineGoogle Scholar27. ROGERSTAHL SJ: Corrélation entre l'épreuve d'ammoniémie provoquée et l'histopathologie hépatique. C. R. Soc. Biol. (Par.) 146: 1786, 1952. MedlineGoogle Scholar28. POPPERELIASPETTY HHDE: Vascular pattern of the cirrhotic liver. Amer. J. Clin. Path. 22: 717, 1952. CrossrefMedlineGoogle Scholar29. STAHLBOCKELIMLER JRM: Effets de l'arginine sur les hyperammoniémies provoquées dans la cirrhose. Rev. Med. Suisse Rom. 80: 308, 1960. MedlineGoogle Scholar30. NATHANSFAHEYSHIP DJLAG: Sites of origin and removal of blood ammonia formed during glycine infusion: effect of 1-arginine. J. Lab. Clin. Med. 51: 124, 1958. Google Scholar31. HARPERNAJARIANSILEN HAJSW: Effect of intravenously administered amino acids on blood ammonia. Proc. Soc. Exp. Biol. Med. 92: 558, 1956. CrossrefMedlineGoogle Scholar32. DAWSONDE GROOTEROSENTHALSHERLOCK AMJWSS: The effects of Diamox on ammonia metabolism in liver disease. Clin. Sci. 16: 413, 1957. MedlineGoogle Scholar33. TYORSIEKER MPHO: Biochemical, blood gas and peripheral circulatory alterations in hepatic coma. Amer. J. Med. 27: 50, 1959. CrossrefMedlineGoogle Scholar34. MURRAYDAWSONSHERLOCK JFAMS: Circulatory changes in chronic liver disease. Amer. J. Med. 24: 358, 1958. CrossrefMedlineGoogle Scholar35. LIEBERLEFEVRE CSA: Métabolisme ammoniacal et intermédiaire au cours du coma hépatique. Acta Clin. Belg. 13: 328, 1958. CrossrefMedlineGoogle Scholar36. SILVERSTEIN E: Peripheral venous oxygen saturation in patients with and without liver disease. J. Lab. Clin. Med. 47: 513, 1956. MedlineGoogle Scholar37. FISHEREICHFALOON CJRWW: Arteriovenous shunting in palmar erythema; the effect upon blood ammonia determinations. J. Lab. Clin. Med. 51:118, 1958. MedlineGoogle Scholar38. PARNASMOZOLOWSKILEWINSKI JKWW: Ueber des Ammoniakgehalt und die Ammoniakbildung im Blute. IX. Mitteilung: der Zusammenhang des Blutammoniaks mit der Muskelarbeit. Biochem Z. 188: 15, 1927. Google Scholar39. STAHLBOCKEL JR: L'ammoniémie dans le diagnostic des hémorragies digestives. Strasbourg Med. 6: 389, 1956. Google Scholar40. STAHLBOCKEL JR: L'ammoniémie post-hémorragique. Sa valeur dans le diagnostic des hemorrhagies digestives. Rev. Franc. Etud. Clin. Biol. 3: 593, 1958. MedlineGoogle Scholar41. STAHLBOCKELIMLER JRM: L'ammoniémie artérielle post-hémorragique dans le diagnostic des hémorragies digestives. Rev. Franc. Etud. Clin. Biol. 4: 462, 1959. MedlineGoogle Scholar42. IMLER M: Intérêt du dosage de l'ammoniémie artérielle dans le diagnostic des hémorragies digestives. These de Strasbourg, 1960. Google Scholar43. MCDERMOTT WV: A single discriminatory test for upper gastro-intestinal hemorrhage. New Engl. J. Med. 257: 1161, 1957. CrossrefMedlineGoogle Scholar44. VANAMEEPOPPELL PJW: Hepatic coma. Med. Clin. N. Amer. 44: 765, 1960. CrossrefMedlineGoogle Scholar45. SUMMERSKILLWOLFEDAVIDSON WHSJCS: The metabolism of ammonia and α-keto-acids in liver disease and hepatic coma. J. Clin. Invest. 36: 361, 1957. CrossrefMedlineGoogle Scholar46. SHERLOCK S: Pathogenesis and management of hepatic coma. Amer. J. Med. 24: 805, 1958. CrossrefMedlineGoogle Scholar47. SHERLOCKSUMMERSKILLWHITEPHEAR SWHLPEA: Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet 2: 453, 1954. CrossrefGoogle Scholar48. WEBSTERGABUZDA LTGJ: Ammonium uptake by the extremities and brain in hepatic coma. J. Clin. Invest. 37: 414, 1958. CrossrefMedlineGoogle Scholar49. STAHLBOCKEL JR: Anémie et toxicité de l'ammoniaque au cours de la cirrhose. Path. Biol. (Par.) 7: 152, 1959. Google Scholar50. READLAIDLAWHASLAMSHERLOCK AEJRMS: Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia. Clin. Sci. 18: 409, 1959. MedlineGoogle Scholar51. OWENTYORFLANAGANBERRY EEMPJFJN: Kidney as source of blood ammonia in patients with liver disease: effect of acetolamide. J. Clin. Invest. 39: 288, 1960. CrossrefMedlineGoogle Scholar52. VANAMEEPOPPELLGLICKSMANNRANDALLROBERTS PJWASHTKE: Respiratory alkalosis in hepatic coma. Arch. Intern. Med. 97: 762, 1956. CrossrefGoogle Scholar53. ROBERTSTHOMPSONPOPPELL KERFJW: Respiratory alkalosis accompanying ammonium toxicity. J. Appl. Physiol. 9: 367, 1956. CrossrefMedlineGoogle Scholar54. LAWRENCEJACQUEZDIENSTPOPPELLRANDALLROBERTS WJASGJWHTKE: The effects of changes in blood pH on the plasma total ammonia level. Surgery: 42: 50, 1957. MedlineGoogle Scholar55. JACQUEZPOPPELLVANAMEELAWRENCEROBERTS JAJWPWKE: Significance of partial pressure of ammonia in ammonia toxicity. Clin. Res. Proc. 5: 20, 1957. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Strasbourg, FranceFrom the Clinique Médicale B, Faculté de Médecine, Strasbourg, France.Presented as the Lilly Lecture at the Forty-third Annual Session of The American College of Physicians, Philadelphia, Pennsylvania, April 9-13, 1962.Requests for reprints should be addressed to Jules Stahl, M.D., Faculté de Médecine, Strasbourg, France. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA Trial of Ornithine Phenylacetate and the Arc of Ammonia's History in the Management of Overt Hepatic EncephalopathyRisk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosisComparison of Arterial vs Venous Ammonia Levels in Hepatic EncephalopathyImportant Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN ConsensusLow-Value Levels: Ammonia Testing Does Not Improve the Outcomes of Overt Hepatic EncephalopathyAcute Hepatic Failure and NutritionElevation of Preoperative Ammonia Level Is Not Associated With the Incidence of Postoperative Delirium in Patients with Liver Transplantation: A Propensity Score Matching AnalysisAltered cognitive control network is related to psychometric and biochemical profiles in covert hepatic encephalopathyAmmoniaAn E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary StudyGABA-ergic tone hypothesis in hepatic encephalopathy – RevisitedTowards Chronic Liver Dysfunction Self-monitoring: a Proof-of-Concept StudyFeatures of Hepatic EncephalopathyHepatic encephalopathy and photobiomodulation: experimental models and clinical featuresShould venous ammonia be used in decision‐making acute liver failure patients?Altered Mental Status in the Emergency DepartmentNitrogen and Protein ParametersA CLINICAL STUDY OF HEPATIC ENCEPHALOPATHY IN CHRONIC LIVER DISEASE WITH REFERENCE TO SERUM AMMONIA IN A TERTIARY CARE HOSPITAL OF NORTH EAST INDIASerum Ammonia is Associated With Transplant-free Survival in Hospitalized Patients With Acutely Decompensated CirrhosisPutative precipitating factors for hepatic encephalopathy in dogs: 118 cases (1991–2014)Refining the Ammonia HypothesisPathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic InflammationIntensivtherapie bei akutem und chronischem LeberversagenAkutes und chronisches LeberversagenPreventive measures for recurrent hepatic encephalopathy in a hemodialysis patientPathophysiology, diagnosis, and management of hepatic encephalopathyA Current Review of the Diagnostic and Treatment Strategies of Hepatic EncephalopathyRevision and update on clinical practice guideline for liver cirrhosisHepatic encephalopathy: An approach to its multiple pathophysiological featuresHepatic EncephalopathyCannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in miceEvaluation of Liver FunctionNitric Oxide, Ammonia, and CRP Levels in Cirrhotic Patients With Hepatic EncephalopathyOrganic osmolytes in hyponatremia and ammonia toxicityComplications of Liver CirrhosisComplications of CirrhosisCorrelação entre a amônia e o potencial evocado relacionado a eventos (P300) em pacientes cirróticosThe liver, the brain and nitrogen metabolismDetecção de encefalopatia hepática mínima através de testes neuropsicológicos e neurofisiológicos e o papel da amônia no seu diagnósticoA 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in ratsCase files of the Children's Hospital of Michigan Regional Poison Control Center: The use of carnitine for the management of acute valproic acid toxicityMyth: Interpretation of a single ammonia level in patients with chronic liver disease can confirm or rule out hepatic encephalopathyComparison of various doses of carbon 13-labeled aminopyrine for a carbon 13-labeled aminopyrine demethylation blood test in healthy dogsHepatic EncephalopathyBreath Ammonia Testing for Diagnosis of Hepatic EncephalopathyRelationship between tumor necrosis factor‐alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failureOral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shuntsKinetic analysis of demethylation of 13C-aminopyrine in healthy dogsBlood ammonia determination in cirrhosis: Still confusing after all these years?Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathyCorrelation between ammonia levels and the severity of hepatic encephalopathyAmmonia levels and the severity of hepatic encephalopathyLeberzirrhose und FolgeerkrankungenAltered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathyExtracorporeal Treatment in Fulminant Hepatic Failure: Pathophysiologic ConsiderationsHyperammonemic EncephalopathyHepatic encephalopathyHelicobacter pylori is not a risk factor for hepatic encephalopathyHepatic encephalopathyDiagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory TestsHepatic Encephalopathy in Liver CirrhosisPartial pressure of ammonia versus ammonia in hepatic encephalopathyLovastatin decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in ratsCerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathyProton Magnetic Resonance Spectroscopy (1H-Mrs) Findings for The Brain in Patients With Liver Cirrhosis Reflect The Hepatic Functional ReserveAmino acid metabolism in liver diseaseRecent Progress in the Treatment of Fulminant Hepatic Failure in JapanHepatic encephalopathy and ascitesThe Involvement of Ammonia with the Mechanisms that Enhance Gaba-Ergic Neurotransmission in Hepatic FailureHyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasmaMANAGEMENT OF PORTAL HYPERTENSION AND ITS COMPLICATIONSEffect of prostaglandin E1 on ammonia concentration in blood of patients with hepatic resectionDetermination of ammonia in ear-lobe capillary blood is an alternative to arterial blood ammoniaComplications of Chronic Liver DiseaseRegional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathyChanges in distribution and activity of glutamine synthetase in carbon tetrachloride-induced cirrhosis in the rat: Potential role in hyperammonemiaPortosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled studyEarly and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosisAwakenings to the pathogenicity of urease and the requirement for continuous long term therapyBinding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbitHepatische Enzephalopathie: Pathophysiologie und BehandlungsmöglichkeitenEffect of Reducing Brain Glutamine Synthesis on Metabolic Symptoms of Hepatic EncephalopathyHyperammonaemia—An Important Cause of Encephalopathy: Three Case ReportsPallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: Clinical correlationsFinally! automated microanalysis of ammonia in arterial bloodCurrent concepts in the pathophysiology of hepatic encephalopathyNeurochemistry of hepatic encephalopathy.Interrelationships of liver and brain with special reference to reye syndromeThe role of methanethiol in the pathogenesis of hepatic encephalopathyInterrelationships of Liver and Brain with Special Reference to Reye SyndromeNeurologic Manifestations of Hepatic DiseasePeriodic Hyperammonemic Encephalopathy Associated With a UreterosigmoidostomyMethoden zur Beurteilung der hepatischen EnzephalopathieProtein- und Aminosäurenstoffwechsel bei Leberinsuffizienz—Infusionstherapeutische und diätetische FolgerungenNutritional Considerations for the Burned PatientProtein- und Aminosäurenstoffwechsel bei Leberinsuffizienz — Infusionstherapeutische und diätetische FolgerungenAmmonia: Its Effects on Biological Systems, Metabolic Hormones, and ReproductionMöglichkeiten und Grenzen des temporären Leberersatzes durch Hämoperfusion mit biologischem MaterialVisual Evoked Potentials in Encephalopathy Induced by Galactosamine, Ammonia, Dimethyldisulfide, and Octanoic AcidHypotyrosinemia, Hypocystinemia, and Failure to Retain Nitrogen During Total Parenteral Nutrition of Cirrhotic PatientsPortosystemic encephalopathy in two young dogs: some additional diagnostic and therapeutic considerationsBeziehungen zwischen Plasmaammoniak, Plasmaaminosäuren und weiteren Parametern bei Leberzirrhose. Zwei HauptkomponentenanalysenAmmonia Metabolism, Urea Cycle Capacity and Their Biochemical AssessmentPortal vein ammonia infusionsLaboratory Assessment of Hepatobiliary DiseaseSubclinical hepatic encephalopathy: Detection, prevalence, and relationship to nitrogen metabolismThe effect of glucose oral administration on hyperammonemia in cirrhoticsUntersuchungen über die Bedeutung von endogenen Toxinen bei der Entstehung des Coma hepaticumCongenital Porta-Caval Shunts in the DogToxicity of Halogenated Oxyquinolines in Dogs. a Clinical StudyEffect of portocaval anastomosis on the incorporation of [U—14C]-D-glucose into protein, cholesterol, and lipid of rat brainSome Concepts on Ammonia, Porta-Systemic Shunts, and Encephalopathy*Ultrastructural responses of the astrocytes to portocaval anastomosis in the ratTHE GLUTAMATE AND GLUTAMINE CONTENT OF RAT BRAIN AFTER PORTOCAVAL ANASTOMOSISDosage de l'ammoniemie en discontinu et en continu par une technique de dialyse automatiqueIntracellular Potassium Concentration During Ammonia IntoxicationTHE ASTROCYTE IN LIVER DISEASEIn-Vivo Studies with a Cation Exchange Resin Mixture in the Removal of Excessive Ammonium from the Extracorporeal Circulation SystemIon-Exchange Method for the Determination of Plasma Ammonia Nitrogen with the Berthelot ReactionHepatic encephalopathyHepatic encephalopathyEFFECT OF CLOPAMIDE AND HYDROCHLOROTHIAZIDE ON PLASMA-AMMONIATHE TOXOPLASMA DYE TEST IN IDIOPATHIC RETROPERITONEAL FIBROSISA PROBLEM IN PERITONEAL DIALYSISAmmoniak als Lebensmittelbestandteil und als MetabolitA Rational Program for the Diagnosis and Treatment of Bleeding Esophageal VaricesEnzymatic ammonia determinations in the blood and cerebrospinal fluid of healthy personsElectrocardiographic Findings in Juvenile Rheumatoid Arthritis: A study of 116 casesThe 198 Au Liver ScanDie Auswirkung einer portocavalen Anastomose bei Lebercirrhose auf freie Plasmaaminosäuren und Blutammoniak nach oraler ProteinzufuhrThe Ammonia Tolerance Test: An Index of Portal HypertensionAmmoniumbelastung bei LeberkrankenBlood AmmoniaBlood Ammonia during Bleeding from Esophageal Varices in Patients with Hepatosplenic SchistosomiasisThe Liver and its DiseasesTHE EFFECT OF ARGININE GLUTAMATE ON ELEVATED BLOOD AMMONIA LEVELS IN CHRONIC LIVER DISEASE 1 January 1963Volume 58, Issue 1Page: 1-24KeywordsAmmoniaBloodCirrhosisComaHematologic testsHemorrhageIntoxicationLiver diseasesMeatSalts Issue Published: 1 January 1963 Copyright & PermissionsCopyright ©, 1963, by The American College of PhysiciansPDF downloadLoading ...